Abstract
Corneal neovascularization (CNV) can induce severe visual impairment and even blindness. Current treatments have limited efficacy and some undesirable side effects. Phototherapy (PT) is a modern medical technique in CNV treatment and worth further improvement. Nanotechnology has various advantages and nanoparticle-mediated drug delivery also contributes to CNV elimination. Phototherapy combined with functional nanoparticles featuring photoacoustic imaging contrast properties can accomplish accurate and safe inhibition of CNV, thus is promising in clinical application.
Original language | English |
---|---|
Pages (from-to) | 99-101 |
Number of pages | 3 |
Journal | Chinese Chemical Letters |
Volume | 32 |
Issue number | 1 |
Early online date | 20 Nov 2020 |
DOIs | |
Publication status | Published - Jan 2021 |
Bibliographical note
Acknowledgments:This study was supported in part by the National Key R&D Program of China (Nos. 2018YFA0107301 and 2018YFA0107304), the National Natural Science Foundation of China (NSFC, Nos. 81770894, 81901876, 81470602 and 81330022) and the Fundamental Research Funds for the Central Universities (Nos. 20720190088 and 20720200019), the Medical and Health Key Project of Xiamen (No. 3502Z20191106), and the Program for New Century Excellent Talents in University, China (No. NCET-13-0502).
Keywords
- Corneal neovascularization
- Phototherapy
- Nanotechnology
- R-nanoICG
- Photoacoustic imaging